BJERKHOLT ERIC

Average Profitability
21.76%
Insider Buys Quantity
12
Insider Buys Sum
$718,508.51
Insider Sells Quantity
2
Insider Sells Sum
$101,989.14

Insider Activity of BJERKHOLT ERIC

According to the SEC Form 4 filings, BJERKHOLT ERIC, being in a position of

  1. director at Cerus Corporation,
    оver the last 12 months, has bought 10000 shares for $16,200, and sold 0 shares,
    over all time since 2020-01-29, has bought 65000 shares for $209,351, and sold 0 shares.

The largest purchase of all time was on 2023-09-11 and amounted to 10000 shares of Mirum Pharmaceuticals, Inc. for $296,492.

The largest sale of all time was on 2014-08-27 and amounted to 10000 shares of Viracta Therapeutics, Inc. for $80,000.

Biography of BJERKHOLT ERIC

No biography is available at this moment.

2024-03-27PurchaseMirum Pharmaceuticals, Inc.
MIRM
CHIEF FINANCIAL OFFICER
2,000
0.0042%
$24.80$49,600+53.05%
2024-03-18PurchaseMirum Pharmaceuticals, Inc.
MIRM
CHIEF FINANCIAL OFFICER
2,000
0.0043%
$25.80$51,600+43.57%
2023-12-13PurchaseCerus Corporation
CERS
director
10,000
0.005%
$1.62$16,200+4.71%
2023-09-11PurchaseMirum Pharmaceuticals, Inc.
MIRM
Chief Financial Officer
10,000
0.0254%
$29.65$296,492-5.85%
2023-08-21PurchaseCerus Corporation
CERS
director
10,000
0.0056%
$1.72$17,151+5.44%
2023-05-23PurchaseCerus Corporation
CERS
director
5,000
0.0029%
$2.00$10,000-3.61%
2020-01-29PurchaseCerus Corporation
CERS
director
40,000
0.025%
$4.15$166,000+47.63%
2015-07-24SaleViracta Therapeutics, Inc.
VIRX
EVP, CFO & Corp. Secretary
6,358
0.0307%
$3.46$21,989-15.63%
2014-08-27SaleViracta Therapeutics, Inc.
VIRX
EVP, CFO & Corp. Secretary
10,000
0.0161%
$8.00$80,000-70.96%
2010-10-08PurchaseViracta Therapeutics, Inc.
VIRX
Sr. VP, CFO & Corp. Secretary
100,000
0.0711%
$0.31$30,850+17.24%
2010-06-30PurchaseViracta Therapeutics, Inc.
VIRX
Sr. VP, CFO & Corp. Secretary
238,243
0.0628%
$0.28$65,517-14.89%
2009-10-30PurchaseViracta Therapeutics, Inc.
VIRX
Sr. VP, CFO & Corp. Secretary
3,331
–
$0.22$733+62.16%
2009-04-03PurchaseViracta Therapeutics, Inc.
VIRX
Senior VP and CFO
6,663
–
$0.22$1,466+110%
2007-03-13PurchaseViracta Therapeutics, Inc.
VIRX
Sr. VP, Corp. Dev. & Finance
3,000
0.0104%
$4.30$12,900-36.9%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.